🟢 Sellas Life Sciences is trading 10% up today amid broader biotech strength

Sellas Life Sciences is trading at $11.54, up 10.01%, amid stronger biotech-sector sentiment.

• Biotech ETF XBI was reported up 2.10%, alongside industry M&A and positive clinical-trial news.
• No clear company-specific announcement on October 20 explains the move. Recent attention has focused on the CEO’s anniversary remarks and investor speculation about clinical programs, not a confirmed deal or clinical update.
• The stock also rose 5.11% on October 19.